UNVERIFIEDSingle Source
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News|4/1/2026
P
Pharmalot
165 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
83
Activity (Last 30 Days)
2
3
1
3
1
1
2
2
1
2
1
3
1
4
1
1
2
2
1
2
1
2026-03-052026-04-02
Top Publishers
Stat News83 stories
Stories (Latest First)
LINDYsurvived 3 days
STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization
Stat News|3/30/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|3/27/2026
UNVERIFIEDSingle Source
STAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Iran war’s impact on pharma supply chain, a Pfizer Lyme vaccine, and more
Stat News|3/23/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about TrumpRx expectations, a high-dose version of Wegovy, and more
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a Lilly weight loss trial, TrumpRx shortcomings, and more
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: A Maryland legislator wants pharma and patient groups to disclose ties to disease awareness campaigns
Stat News|3/18/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Trump’s drug pricing moves, a GSK asthma drug, and more
Stat News|3/17/2026
UNVERIFIEDSingle Source
STAT+: Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says
Stat News|3/16/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more
Stat News|3/16/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|3/13/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about the FDA warning Novo Nordisk, Lilly investing in China, and more
Stat News|3/11/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a U.S. senator probing FDA, BioNTech founders leaving, and much more
Stat News|3/10/2026
UNVERIFIEDSingle Source
STAT+: Large drugmakers are developing fewer antibiotics, analysis finds
Stat News|3/10/2026
UNVERIFIEDSingle Source
STAT+: Pharmalot: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA-UniQure tussle, a Pfizer obesity drug approval in China, and more
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Gilead and South Africa are negotiating a license for local production of new HIV drug
Stat News|3/5/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA-UniQure feud, Pfizer’s ‘problem’ with the agency, and more
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Trump’s MFN deals, 340B program controversies, and much more
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|2/27/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA and a ‘smear campaign,’ Cigna buying a large pharmacy, and more
Stat News|2/27/2026
UNVERIFIEDSingle Source
STAT+: Justice Department backs AbbVie in its bid to overturn a Colorado law guiding a drug discount program
Stat News|2/26/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more
Stat News|2/20/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about the FDA pushing OTC meds, its new trial standards, and much more
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistance
Stat News|2/18/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|2/13/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and more
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Trump administration revives effort to launch pilot initiative reworking drug discount program
Stat News|2/10/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about FDA rejecting a rare disease drug, a warning to a Hims compounding pharmacy and more
Stat News|2/10/2026
UNVERIFIEDSingle Source
STAT+: FDA warned a Hims & Hers compounder after finding bugs and failing to report a serious side effect
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
Stat News|2/7/2026
UNVERIFIEDSingle Source
STAT+: Up and down the ladder: The latest comings and goings
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and more
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about Super Bowl drug ads, an FTC deal with Express Scripts, and more
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about a Pfizer obesity pill, Florida’s failed drug importation plan, and more
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: As U.S. officials move to reduce animal testing in research, focus may shift to restrictions on imports
Stat News|2/3/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Pharmalittle: We’re reading about pharma lobbying, an FDA gene-editing pathway, and more
Stat News|1/26/2026